Differentiation of desquamative interstitial pneumonia (DIP) from pulmonary adenocarcinoma by immunocytochemistry

Histopathology. 1998 Aug;33(2):129-35. doi: 10.1046/j.1365-2559.1998.00463.x.

Abstract

Aim: After a misdiagnosis of pulmonary adenocarcinoma as desquamative interstitial pneumonia (DIP), we investigated whether immunohistochemical markers could differentiate these conditions.

Methods and results: Three cases of DIP and one pulmonary adenocarcinoma masquerading as DIP were studied by light and electron microscopy. All cases were mucin-negative. The cases of DIP were CD68 positive but cytokeratin-negative. The adenocarcinoma was cytokeratin-positive (AE1/3 and CAM5.2), as well as showing some CD68-positive cells. Markers for carcinoma (CEA, Ber-EP4, and Leu M1) were negative in all cases. Ultrastructurally the adenocarcinoma appeared to be derived from Type II pneumocytes.

Conclusion: Before a diagnosis of DIP is made, cytokeratin markers should be used.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / chemistry
  • Adenocarcinoma / pathology*
  • Adenocarcinoma / ultrastructure
  • Adult
  • Biomarkers / analysis*
  • Diagnosis, Differential
  • Fatal Outcome
  • Female
  • Humans
  • Immunohistochemistry
  • Lung / chemistry
  • Lung / ultrastructure
  • Lung Diseases, Interstitial / pathology*
  • Lung Neoplasms / chemistry
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / ultrastructure
  • Male
  • Microscopy, Electron
  • Middle Aged

Substances

  • Biomarkers